Table 2 | Control group | CKD Stages I-V | p |
---|---|---|---|
N=24 | N=80 | ||
E/A | 0.8 (0.65-1.1) | 0.9 (0.8-1.2) | NS |
E/E’ | 7.5±2.1 | 9.9±4.7 | NS |
Hypertrophy [%] | 52 | 95.3 | NS |
Diastolic dysfunction [%] | 29 | 93.2 | NS |
Contractility dysfunction [%] | 57.1 | 52.8 | NS |
Stenosis | 0 | 3.2 | NS |
Mitral valve fibrosis | 53.3 | 81.3 | P<0.01 |
Aortic valve fibrosis | 0 | 14.1 | NS |
Mitral valve calcification | 13.3 | 14.1 | NS |
Aortic valve calcification | 0 | 30.2 | P<0.02 |
IM | 46.7 | 63.1 | NS |
IA | 0 | 6.7 | NS |
IT | 16.7 | 43.8 | NS |